The University of Edinburgh
In-vitro exposure of blue light on retinal pigment epithelium and its relevance to age-related macular degeneration
Abstract
dc:description.abstractAge-related macular degeneration (AMD) is a complex disease arising from the interaction of multiple genes and environmental factors. AMD initially affects the pigmented monolayer in retina called retinal pigment epithelium (RPE) which is responsible for photoreceptor homeostasis. AMD causes the loss of the central vision and is the most common cause of registerable blindness in the developed world, and for patients with the atrophic or dry form of the disease there is no cure. Most of the electronic devices and ambient lighting today use light-emitting diode (LED) technology, emitting strong blue-light (470 nm) which is an exogenous risk factor for AMD. This study aimed to understand better the effect of blue-light (470 nm) on RPE cells and to leverage this understanding to develop a blue-light induced in-vitro disease model that recapitulates cellular features of AMD. To this end, we designed an ad-hoc LED array to illuminate RPE cells cultured in multi-well plates. This allowed us to perform standard biochemical assays and immunostaining such as; detection of reactive oxygen species, Zonula occludens-1 (ZO-1) staining, Protein Kinase C-ζ (PKC-ζ) inhibition, senescence associated β-galactosidase staining and Mitotracker™. Then using specialists Electric Cell-substrate Impedance Sensing (ECIS) multi-well arrays, the time-course effect of blue-light on RPE cells was investigated and quantified in a label free manner. We showed that blue-light exposure induced a dose-dependent decrease in the barrier function associated with tight junction formation before cell coverage declined. This damage induced by blue-light on tight junctions was mediated by oxidative stress through PKC-ζ activation. Then we demonstrated that ARPE-19 cells exposed to blue-light recapitulates cellular features associated with AMD; senescence, mitochondrial dysfunction and loss of barrier function, before cell coverage declined. Comparison of blue-light induced AMD model against TBHP- and H2O2- induced models showed statistically different response from APRE-19 cells. Blue-light induced AMD in-vitro model also demonstrated potential advantages such as easier modulability and in-situ experiments for mimicking in-vivo AMD development process before RPE cell death. This research has given us insights for designing new high throughput screening assays to test efficiency of novel therapies such as PKC-ζ inhibition and has shown proof of principle for a new model for AMD based on blue-light damage.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2021
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Ozkaya, Ege Kaan
- Advisors dc:contributor.advisor
-
- Bagnaninchi, Pierre
- Dhillon, Baljean
Subjects
dc:subject × 4Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/1442